Dyspnoea in COVID-19 recovery beyond the intensive care unit: the potential impact of inspiratory muscle weakness

Emerging evidence confirms that dyspnoea and inspiratory muscle weakness persist for up to 6 months following mechanical ventilation with #COVID19 pneumonia. Screening for inspiratory muscle weakness should be prioritised, as it may be treatable. https://bit.ly/3CBQXO2

Detalles Bibliográficos
Autor principal: Bissett, Bernie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2023
Materias:
Editorials
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9841315/
https://www.ncbi.nlm.nih.gov/pubmed/36687360
http://dx.doi.org/10.1183/23120541.00521-2022

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9841315/
https://www.ncbi.nlm.nih.gov/pubmed/36687360
http://dx.doi.org/10.1183/23120541.00521-2022

Ejemplares similares